Full Year 2025 Revenue reached RMB13.6 billion, up 3.8% year-over-year- -Full Year 2025 International Transaction Volume reached RMB14.0 billion, up 38.6% year-over-year- - ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of ...